Methylphenidate Hydrochloride 50268-0548-12
- Manufacturer
- Avpak
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- April 22, 2021
- Listing Expires
- December 31, 2027
- Application
- ANDA211009
Active Ingredients
| Ingredient | Strength |
|---|---|
| Methylphenidate Hydrochloride | 54 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
50268-0548-12Selected20 BLISTER PACK in 1 BOX (50268-548-12) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (50268-548-11)